Get started
AngioDynamics, Inc.AngioDynamics, Inc.AngioDynamics, Inc.

AngioDynamics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ANGO chart


Full chart

ANGO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪273.87 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.04 USD
Net income (FY)
‪−184.35 M‬ USD
Revenue (FY)
‪303.91 M‬ USD
Shares float
‪38.64 M‬
Beta (1Y)
0.05

Employees


Employees (FY)
748
Change (1Y)
−67 −8.22%
Revenue / Employee (1Y)
‪406.30 K‬ USD
Net income / Employee (1Y)
‪−246.46 K‬ USD

About AngioDynamics, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
James Christopher Clemmer
Website
angiodynamics.com
Headquarters
Latham
Founded
1988
FIGI
BBG000BB5621
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ANGO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where ANGO is featured.

See all sparks 

Frequently Asked Questions


The current price of ANGO is 7.41 USD — it has increased by 3.71% in the past 24 hours. Watch AngioDynamics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AngioDynamics, Inc. stocks are traded under the ticker ANGO.
ANGO stock has risen by 3.86% compared to the previous week, the month change is a 8.88% rise, over the last year AngioDynamics, Inc. has showed a 11.09% increase.
We've gathered analysts' opinions on AngioDynamics, Inc. future price: according to them, ANGO price has a max estimate of 14.00 USD and a min estimate of 12.00 USD. Watch ANGO chart and read a more detailed AngioDynamics, Inc. stock forecast: see what analysts think of AngioDynamics, Inc. and suggest that you do with its stocks.
ANGO reached its all-time high on Nov 5, 2021 with the price of 32.00 USD, and its all-time low was 5.26 USD and was reached on Mar 25, 2024. View more price dynamics on ANGO chart.
See other stocks reaching their highest and lowest prices.
ANGO stock is 6.59% volatile and has beta coefficient of 0.05. Track AngioDynamics, Inc. stock price on the chart and check out the list of the most volatile stocks — is AngioDynamics, Inc. there?
Today AngioDynamics, Inc. has the market capitalization of ‪284.03 M‬, it has decreased by −0.59% over the last week.
Yes, you can track AngioDynamics, Inc. financials in yearly and quarterly reports right on TradingView.
AngioDynamics, Inc. is going to release the next earnings report on Jan 2, 2025. Keep track of upcoming events with our Earnings Calendar.
ANGO earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.15 USD resulting in a 25.00% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about AngioDynamics, Inc. earnings.
AngioDynamics, Inc. revenue for the last quarter amounts to ‪67.49 M‬ USD, despite the estimated figure of ‪67.93 M‬ USD. In the next quarter, revenue is expected to reach ‪70.93 M‬ USD.
ANGO net income for the last quarter is ‪−12.80 M‬ USD, while the quarter before that showed ‪−13.45 M‬ USD of net income which accounts for 4.84% change. Track more AngioDynamics, Inc. financial stats to get the full picture.
No, ANGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 7, 2024, the company has 748.00 employees. See our rating of the largest employees — is AngioDynamics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AngioDynamics, Inc. EBITDA is ‪−5.02 M‬ USD, and current EBITDA margin is −2.01%. See more stats in AngioDynamics, Inc. financial statements.
Like other stocks, ANGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AngioDynamics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AngioDynamics, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AngioDynamics, Inc. stock shows the sell signal. See more of AngioDynamics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.